Hologic (NASDAQ:HOLX) issued its quarterly earnings data on Thursday. The medical equipment provider reported $0.55 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.50 by $0.05, Bloomberg Earnings reports. The firm had revenue of $791.10 million during the quarter, compared to analysts’ expectations of $785.80 million. Hologic had a net margin of 24.70% and a return on equity of 21.69%. Hologic’s revenue for the quarter was up 7.7% on a year-over-year basis. During the same period in the prior year, the company posted $0.52 earnings per share. Hologic updated its Q2 guidance to $0.53-0.54 EPS.
Shares of Hologic (NASDAQ HOLX) traded down $1.65 on Thursday, hitting $38.80. 3,180,000 shares of the stock were exchanged, compared to its average volume of 2,480,000. The firm has a market capitalization of $10,700.00, a price-to-earnings ratio of 14.70, a P/E/G ratio of 1.89 and a beta of 0.77. The company has a debt-to-equity ratio of 0.79, a current ratio of 0.79 and a quick ratio of 0.61. Hologic has a 1-year low of $35.76 and a 1-year high of $46.80.
In other news, Director Elaine Ullian sold 9,282 shares of the company’s stock in a transaction dated Monday, November 13th. The shares were sold at an average price of $40.50, for a total transaction of $375,921.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP Karleen Marie Oberton sold 1,023 shares of the company’s stock in a transaction dated Monday, November 20th. The shares were sold at an average price of $39.84, for a total transaction of $40,756.32. The disclosure for this sale can be found here. 0.79% of the stock is currently owned by corporate insiders.
Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays.
Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.